Login
Products
Login
Home
Alerts
Search
Watchlist
Products

Rubfila International Ltd

RUBFILA
BSE
73.63
0.41%
Last Updated:
29 Apr '26, 4:00 PM
Company Overview
Alert
Watchlist
Note

Rubfila International Ltd

RUBFILA
BSE
73.63
0.41%
29 Apr '26, 4:00 PM
Company Overview
Add Alert
Add to Watchlist
Edit Note
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
400Cr
Close
Close Price
73.63
Industry
Industry
Rubber - Products
PE
Price To Earnings
13.81
PS
Price To Sales
0.68
Revenue
Revenue
589Cr
Rev Gr TTM
Revenue Growth TTM
10.87%
PAT Gr TTM
PAT Growth TTM
0.99%
Peer Comparison
How does RUBFILA stack up?
Compare up to 10 companies side by side across valuation, profitability, and growth.
RUBFILA
VS

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterMar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025
Revenue
RevenueCr
113124115103129130135138147145150147
Growth YoY
Revenue Growth YoY%
-14.2-5.92.22.813.45.417.534.014.711.311.56.3
Expenses
ExpensesCr
10411510497118119125126135135139138
Operating Profit
Operating ProfitCr
10911611119121310119
OPM
OPM%
8.67.19.25.58.78.46.98.68.56.87.35.9
Other Income
Other IncomeCr
141111221222
Interest Expense
Interest ExpenseCr
000000000000
Depreciation
DepreciationCr
233333333333
PBT
PBTCr
910941010811119117
Tax
TaxCr
322122233232
PAT
PATCr
688377688786
Growth YoY
PAT Growth YoY%
-44.1-32.010.386.820.4-10.5-19.7182.317.2-6.232.5-30.9
NPM
NPM%
5.26.56.62.75.55.54.55.85.64.65.33.8
EPS
EPS
1.11.51.40.51.21.31.11.51.61.21.51.0

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025TTM
Revenue
RevenueCr
215214258323477457470550589
Growth
Revenue Growth%
-0.520.725.247.6-4.12.817.27.1
Expenses
ExpensesCr
183190234274412420434506547
Operating Profit
Operating ProfitCr
322424496537364542
OPM
OPM%
14.911.39.215.213.68.27.78.17.1
Other Income
Other IncomeCr
435337867
Interest Expense
Interest ExpenseCr
000000000
Depreciation
DepreciationCr
436679111111
PBT
PBTCr
332422456035334038
Tax
TaxCr
11661216971010
PAT
PATCr
211817334526252929
Growth
PAT Growth%
-16.0-4.798.133.5-41.9-2.115.9-3.2
NPM
NPM%
9.88.36.510.39.45.75.45.34.8
EPS
EPS
4.83.73.36.48.34.84.65.55.3

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Dec 2025
Equity Capital
Equity CapitalCr
232425272727272727
Reserves
ReservesCr
89109128170208225243267276
Current Liabilities
Current LiabilitiesCr
161538403733313631
Non Current Liabilities
Non Current LiabilitiesCr
101016192226292930
Total Liabilities
Total LiabilitiesCr
140158209255294311330358364
Current Assets
Current AssetsCr
776478110127123151184188
Non Current Assets
Non Current AssetsCr
6394131145167188179174176
Total Assets
Total AssetsCr
140158209255294311330358364

Cash Flow

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Operating Cash Flow
Operating Cash FlowCr
437371435302825
Investing Cash Flow
Investing Cash FlowCr
-11-39-43-20-26-24-1-7
Financing Cash Flow
Financing Cash FlowCr
82610-7-10-7-7
Net Cash Flow
Net Cash FlowCr
10041-32011
Free Cash Flow
Free Cash FlowCr
-11116-8542719
CFO To PAT
CFO To PAT%
20.3207.5218.942.878.2117.1109.986.3
CFO To EBITDA
CFO To EBITDA%
13.3152.6155.929.253.881.377.656.8

Ratios

Consolidated
Standalone
Financial YearMar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
325195116323500335370345
Price To Earnings
Price To Earnings
15.411.06.99.711.212.914.611.7
Price To Sales
Price To Sales
1.50.90.51.01.10.70.80.6
Price To Book
Price To Book
2.91.50.81.62.11.31.41.2
EV To EBITDA
EV To EBITDA
10.08.04.76.47.58.89.56.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
29.727.527.934.530.229.127.826.6
OPM
OPM%
14.911.39.215.213.68.27.78.1
NPM
NPM%
9.88.36.510.39.45.75.45.3
ROCE
ROCE%
29.318.014.822.925.614.012.113.5
ROE
ROE%
18.913.311.116.919.010.39.410.0
ROA
ROA%
15.111.28.113.115.28.37.78.2
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
### **Overview** Rubfila International Ltd (RIL) is the holding company of a diversified manufacturing group with core operations in two distinct yet strategically aligned consumer and industrial segments: 1. **Latex rubber thread manufacturing** under the flagship **Rubfil** brand (Rubfila International Ltd). 2. **Tissue and hygiene products** through its wholly-owned subsidiary, **Premier Tissues India Ltd (PTIL)**, which also operates in the **home care product** segment. RIL has built a strong reputation over decades, with the **Rubfil brand established for nearly 40 years**, initially through Malaysian origins and later strengthened under RIL’s ownership since 1995. The company maintains leadership positions in both domestic and international markets and is actively pursuing growth through geographic expansion, capacity enhancement, and operational optimization. --- ### **Core Business Segments** #### **1. Rubfila International Ltd – Rubber Thread Manufacturing** - **Primary Segment**: Manufacture and sale of heat-resistant **latex rubber thread**, a critical raw material for the **innerwear and garment industries**. - **Market Position**: **Market leader in India** with the **largest manufacturing capacity** of 20,000 metric tons per annum (expanded via new production lines commissioned in 2020 and 2021). - **Revenue Mix (as of FY22)**: - Domestic (India): ₹3,294.17 crores - Export (Asia, America, Europe, Africa): ₹854.99 crores (~21% of total sales) - **Export target**: 25% of total sales (targeted as of 2020, on track). #### **2. Premier Tissues India Ltd – Tissue & Hygiene Products** - **Primary Segment**: Manufacture and sale of **tissue paper**, **hygiene products**, and **home care items** (e.g., dish wash liquid, toilet cleaner, detergent). - **Brands**: Premier (premium), Royal (value segment). - **Market Position**: Recognized as one of India’s **most respected tissue brands**, with strong brand equity and a growing national footprint. - **Growth**: Tissue sales grew **44% YoY** in FY23, driven by post-pandemic hygiene demand and product diversification. --- ### **Strategic Highlights (2022–2025)** #### **Capacity Expansion & Operational Scale** - **Rubfila**: - **300% increase in production capacity** since 2017; total capacity now at **20,000 MT/year**. - New production line in Udumalpet, Tamil Nadu, commissioned in 2020 despite pandemic disruptions. - Expansion of Tamil Nadu plant planned to capture greater share of **global rubber thread market**. - **Premier Tissues**: - **Asset-light model** adopted to reduce logistical costs. - Establishment of **offsite satellite conversion centers** near high-potential markets: - **West Bengal (Eastern India)** – Operational. - **Western India (near Mumbai)** – Planned. #### **Geographic & Market Expansion** - **Rubfila**: - Aims to expand into **untapped global markets**, leveraging the **strong international brand equity** of 'Rubfil'. - Focus on **Americas** as a new growth frontier; customer development and sampling in progress. - **Export growth trajectory** is upward, supported by increased capacity and new customer acquisitions. - **Premier Tissues**: - Historically strong in **South and West India**; actively expanding in **North and East India**. - **Weak sales infrastructure** and **high logistics costs** from Mysore plant being addressed via **regional conversion units** and **expansion of distributor network**. - Building robust **sales teams** in underpenetrated regions to improve national market presence. #### **Brand & Product Development** - **Rubfil Brand**: - Over **40 years of brand equity**, trusted in global markets. - Serves major hosiery clusters across India (Delhi, Kolkata, Surat, Tirupur, Ahmedabad). - Known for **reliability, quality, and long-standing customer loyalty**, especially in Europe. - **Premier Tissues**: - Launched **new hygiene products** (sanitizing wipes, disinfectant sprays) in 2020–21 to meet pandemic-driven demand. - Expanded into **home care segment** with soft launch in Kerala (2022), now scaling nationally. - **Packaging redesign** and **new product variants** have been well-received. --- ### **Key Strengths** 1. **Dual-Market Leadership**: - Dominant in domestic rubber thread market; respected player in organized tissue segment. 2. **Resilient Demand**: - Core end-use industries (innerwear, hygiene) are **relatively recession-resistant**. 3. **Strong Brand Equity**: - Both **Rubfil** (industrial) and **Premier** (consumer) enjoy high reputation and trust. 4. **Strategic Asset Utilization**: - 11.87 acres of **freehold land in Pollachi** (valued at ₹128.15 million) classified as investment property. - **Leasing manufacturing space** to subsidiary (Premier) for internal efficiency (since 2021). 5. **Long-Term Growth Potential**: - India’s **per capita tissue consumption** (~250 grams) is far below global average (5.2 kg), signaling **huge untapped market**. - Rising income, urbanization, and hygiene awareness support sustained growth. --- ### **Challenges & Risks** #### **Raw Material & Cost Pressures** - **High domestic latex prices** in India due to: - Unfavorable government import policies. - Climate-related fluctuations affecting rubber tapping. - Restricted latex imports and inverted duty structures. - **Disparity** with lower international latex prices (e.g., Malaysia, Thailand) threatens **cost competitiveness**. #### **Competitive Threats** - **Low-cost imports** from **Malaysia and Thailand** (benefiting from **free trade agreements**) create pricing pressure. - **Chinese exporters** dumping excess rubber thread stock. - **Spandex substitution**: Growing use of synthetic **spandex** in elastic tapes and garments poses **long-term threat** to rubber thread demand. #### **Operational & Market Challenges** - **Manpower shortages** in regional markets hindering distribution expansion (as of Aug 2025). - RIL exploring **gig-sector labor models** as alternative solution. - **Domestic market fragmentation**: Organized tissue players face competition from **low-cost unorganized sector**. - **Potential price wars** due to industry-wide **capacity overhang** and new entrants. #### **Supply Chain Risks** - **Volatility in natural rubber supply** due to rubber growers in **Kerala shifting to alternative crops** (due to non-remunerative prices). - **Long-term raw material security** at risk if rubber cultivation continues to decline.